在积极监督措施中，因PSA过高而被诊断需进行活体组织检查的患者将推迟治疗，而替之以通过各种后续测试进行密切监视。
In an active surveillance program, a patient diagnosed with a PSA-prompted biopsy delays treatment. Instead, he is closely monitored with various follow-up tests.